SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-260013
Filing Date
2023-10-20
Accepted
2023-10-20 17:18:59
Documents
14
Period of Report
2023-10-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d535574d8k.htm   iXBRL 8-K 26558
2 EX-99.1 d535574dex991.htm EX-99.1 9581
6 GRAPHIC g535574g1020212219746.jpg GRAPHIC 2826
  Complete submission text file 0001193125-23-260013.txt   163462

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20231020.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20231020_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20231020_pre.xml EX-101.PRE 10813
8 EXTRACTED XBRL INSTANCE DOCUMENT d535574d8k_htm.xml XML 3267
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 231337782
SIC: 2834 Pharmaceutical Preparations